Table 4.
p-value | |
---|---|
GC, ETF, AP2GAMMA, MOVB, AP2, LRF, CHCH, SP1, AP2LAPHA | |
Cellular Development (MCF) | 4.32E-13 |
Organ Development (PSDF) | 2.43E-14 |
Wnt/b-catenin Signaling(CP) | 3.90E-10 |
CKROX, SPZ1, WT1, MZF1, MAZ, TFIII, IK | |
Cellular Development (MCF) | 3.97E-12 |
Tissue Development (PSDF) | 1.23E-12 |
Wnt/b-catenin Signaling (CF) | 1.51E-05 |
AML, COREBINDINGFACTOR, PEBP, OSF2, AML1 | |
Cell-To-Cell Signaling and Interaction (MCF) | 5.29E-05 |
Hematological System Development and Function (PSDF) | 3.08E-05 |
Immune Cell Trafficking (PSDF) | 3.08E-05 |
CACBINDINGPROTEIN, CACD, PAX4, SREBP1 | |
Cellular Development (MCF) | 6.48E-12 |
Organismal Development (PSDF) | 4.92E-16 |
Axonal Guidance Signaling (CP) | 4.26E-05 |
HMGIY, STAT6, STAT1, NFAT | |
Cellular Development (MCF) | 2.43E-08 |
Nervous System Development and Function (PSDF) | 6.45E-18 |
Axonal Guidance Signaling (CF) | 4.24E-04 |
CEBPDELTA, CEBPB, CEBPA | |
Antigen Presentation (MCF) | 4.28E-04 |
Humoral Immune Response (PSDF) | 2.98E-04 |
T Helper Cell Differentiation (CP) | 1.61E-03 |
ZF5, E2F, KROX | |
Gene Expression (MCF) | 6.32E-22 |
Organ Development (PSDF) | 5.59E-16 |
Axonal Guidance Signaling (CP) | 1.13E-12 |
ZTA, BACH2, BACH1 | |
Antigen Presentation (MCF) | 1.35E-06 |
Cell-mediated Immune Response (PSDF) | 1.35E-06 |
NF-kB Signaling (CP) | 1.71E-03 |
CREL, NFKAPPAB65 | |
Cell-To-Cell Signaling and Interaction (MCF) | 2.73E-05 |
Cell-mediated Immune Response (PSDF) | 1.81E-06 |
NF-kB Signaling (CP) | 4.28E-06 |
MAZR, ZNF219 | |
Cellular Development (MCF) | 9.61E-13 |
Nervous System Development and Function (PSDF) | 1.23E-10 |
Axonal Guidance Signaling (CP) | 1.40E-07 |
a Only the top categories with respect to p-value are given